Shares of Straumann Holding AG (OTCMKTS:SAUHY – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the six research firms that are presently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, two have given a hold recommendation, one has assigned a buy recommendation and two have assigned a strong buy recommendation to the company.
A number of research analysts recently weighed in on SAUHY shares. UBS Group raised shares of Straumann from a “sell” rating to a “neutral” rating in a research report on Tuesday, November 4th. Citigroup restated a “sell” rating on shares of Straumann in a research note on Wednesday, October 22nd. The Goldman Sachs Group lowered Straumann from a “strong-buy” rating to a “neutral” rating in a report on Monday, October 13th. Finally, Deutsche Bank Aktiengesellschaft upgraded Straumann from a “hold” rating to a “buy” rating in a report on Friday, October 31st.
View Our Latest Stock Analysis on SAUHY
Straumann Stock Down 0.5%
About Straumann
Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials, and digital solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss.
Featured Articles
- Five stocks we like better than Straumann
- Canadian Penny Stocks: Can They Make You Rich?
- Wall Street’s Sleeping Giant: Is Amazon About to Wake Up?
- Do ETFs Pay Dividends? What You Need to Know
- Checkmate in the Cloud: ServiceNow’s Shopping Spree
- ESG Stocks, What Investors Should Know
- The Contrarian Case for MSTR Amid MSCI Delisting Debacle
Receive News & Ratings for Straumann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Straumann and related companies with MarketBeat.com's FREE daily email newsletter.
